
Join to View Full Profile
345 23rd Ave NSuite 350Nashville, TN 37203
Phone+1 615-983-6000
Fax+1 615-983-6010
Dr. Awh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Duke University HospitalFellowship, Surgical Retina and Vitreous, 1990 - 1992
- MedStar Health Georgetown UniversityResidency, Ophthalmology, 1987 - 1990
- MedStart Georgetown University HospitalInternship, Transitional Year, 1986 - 1987
- University of Mississippi School of MedicineClass of 1986
Certifications & Licensure
- TN State Medical License 1994 - 2025
- NC State Medical License 1990 - 1995
- MD State Medical License 1992 - 1994
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial.Dante J Pieramici, Carl C Awh, Margaret Chang, Andres Emanuelli, Nancy M Holekamp
JAMA Ophthalmology. 2025-03-06 - Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly Injections.Anam Akhlaq, David Williams, W Lloyd Clark, Hannah Khan, Arshad M Khanani
American Journal of Ophthalmology. 2024-02-01 - 1 citationsSUSTAINED BIWEEKLY AFLIBERCEPT FOR REFRACTORY NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The Prospective TRISTAR Study.Eric W Schneider, Mridul K Thomas, Franco M Recchia, David A Reichstein, Carl C Awh
Retina. 2023-05-01
Press Mentions
- Continuous-Release Anti-VEGF for Macular Degeneration Continues to ImpressOctober 13th, 2021
- SUBSPECIALTY NEWS: New AMD Nomenclature, Home-Based OCT, Prior Authorizations, Effects of Missed Ophthalmology Visits, and MoreApril 1st, 2020
- Hypersonic Vitrectomy: Exploring Novel Way of Vitreous RemovalDecember 13th, 2019
- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: